# Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation

> **NCT06430021** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 297 (estimated)

## Conditions studied

- Neuroendocrine Tumors
- MEN1 Mutation

## Interventions

- **BIOLOGICAL:** blood sample

## Key facts

- **NCT ID:** NCT06430021
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-13
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 297 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06430021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06430021, "Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06430021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*